相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
W. Nathaniel Brennen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The dipeptidyl peptidase IV family in cancer and cell biology
Denise M. T. Yu et al.
FEBS JOURNAL (2010)
Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
Hans J. Hammers et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Cancer associated fibroblasts in cancer pathogenesis
Omar E. Franco et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Masayuki Shimoda et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution
Ian Campbell et al.
CANCER RESEARCH (2009)
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
R. M. Eager et al.
CLINICAL ONCOLOGY (2009)
Cancer-associated fibroblasts and tumor growth - bystanders turning into key players
Arne Oestman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer
Ellen Pure
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours
Osamu Dohi et al.
HISTOPATHOLOGY (2009)
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Angelica M. Santos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cells
Sylvia K. E. Messerschmidt et al.
JOURNAL OF CONTROLLED RELEASE (2009)
The Prolyl-Aminodipeptidases and their Inhibitors as Therapeutic Targets for Fibrogenic Disorders
Lucienne Juillerat-Jeanneret et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells
Donald J. Vander Griend et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Debbie Liao et al.
PLOS ONE (2009)
Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites
Saurabh Aggarwal et al.
BIOCHEMISTRY (2008)
Seprase: An overview of an important matrix serine protease
Pamela O'Brien et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow
Sohyun Bae et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts
Elinborg Ostermann et al.
CLINICAL CANCER RESEARCH (2008)
Fibroblast activation protein and chronic liver disease
Xin Maggie Wang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J. Cohen et al.
PANCREAS (2008)
Clinical implications of fibroblast activation protein in patients with colon cancer
Leonard R. Henry et al.
CLINICAL CANCER RESEARCH (2007)
Effect of fibroblast activation protein and α2-antiplasmin cleaving enzyme on collagen types I, III, and IV
Victoria J. Christiansen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity
CY Edosada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly2-Pro1-cleaving specificity
CY Edosada et al.
FEBS LETTERS (2006)
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
S Janssen et al.
PROSTATE (2006)
Fibroblast activation protein:: a serine protease expressed at the remodeling interface in idiopathic pulmonary flbrosis
PS Acharya et al.
HUMAN PATHOLOGY (2006)
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
KN Lee et al.
BLOOD (2006)
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Stefan Bauer et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress
E Sivridis et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer
Y Huang et al.
CANCER RESEARCH (2004)
FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor
T Ramirez-Montagut et al.
ONCOGENE (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
Friends or foes - Bipolar effects of the tumour stroma in cancer
MM Mueller et al.
NATURE REVIEWS CANCER (2004)
Purification, identification and characterisation of seprase from bovine serum
PJ Collins et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion
KN Lee et al.
BLOOD (2004)
Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted activation
D Samel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
SR Denmeade et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Stromal antigen targeting by a humanised monoclonal antibody:: An early phase II trial of sibrotuzamab in patients with metastatic colorectal cancer
RD Hofheinz et al.
ONKOLOGIE (2003)
A practical synthesis of L-valyl-pyrrolidine-(2R)-boronic acid:: Efficient recycling of the costly chiral auxiliary (+)-pinanediol
FS Gibson et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2002)
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells
CM Jakobsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
